Aclaris Therapeutics: Pay

Aclaris Therapeutics paid CEO Neal Walker $3.4M in FY2025 (Dec). No other named executive of that year is on file.

Pay$100 in the stock at the end of FY23 → $287
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Neal WalkerChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
James LoeropChief Business Officer
FY2023 (Dec)
1 year
Kevin BalthaserChief Financial Officer
FY2024 (Dec)Not disclosed
1 year

CEO pay against the pay peers

In FY2023 (Dec), the median CEO pay of the 9 peers with pay on file was $4.4M. The CEO of Aclaris Therapeutics was paid $7.2M, 64% above the median.

  1. 1Kymera Therapeutics
  2. 2Syndax Pharmaceuticals
  3. 3Celldex Therapeutics
  4. 4Anaptysbio
  5. 5Aclaris Therapeutics
  6. 6Nurix Therapeutics
  7. 7Scholar Rock Holding
  8. 8Aldeyra Therapeutics
  9. 9Replimune Group
  10. 10Stoke Therapeutics
  11. 11AlloVir, Inc.Not disclosed
  12. 12BioXcel Therapeutics, Inc.Not disclosed
  13. 13C4 Therapeutics, Inc.Not disclosed
  14. 14Chinook Therapeutics, Inc.Not disclosed
  15. 15Day One Biopharmaceuticals, Inc.Not disclosed
  16. 16Design Therapeutics, Inc.Not disclosed
  17. 17Evelo Biosciences, Inc.Not disclosed
  18. 18IVERIC bio, Inc.Not disclosed
  19. 19Inhibrx, Inc.Not disclosed
  20. 20RAPT Therapeutics, Inc.Not disclosed
  21. 21Selecta Biosciences, Inc.Not disclosed
  22. 22Seres Therapeutics, Inc.Not disclosed
  23. 23VaxcyteNot disclosed
  24. 24Ventyx Biosciences, Inc.Not disclosed
  25. 25iTeos Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.